Home / Resource Library / ODRONEXTAMAB DEMONSTRATES DURABLE COMPLETE RESPONSES IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PROGRESSING AFTER CAR-T THERAPY: OUTCOMES FROM THE ELM-1 STUDY
ODRONEXTAMAB DEMONSTRATES DURABLE COMPLETE RESPONSES IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PROGRESSING AFTER CAR-T THERAPY: OUTCOMES FROM THE ELM-1 STUDY